Pfizer layoff talk boosts stock

While the financial markets teeter, Pfizer stock closed 4 percent higher yesterday as rumors of more layoffs swirled. Never mind that Pfizer already announced big job cuts; the actual implementation appears to be cheering investors as it scares the drugmaker's rank-and-file. Derek Lowe at In the Pipeline hears from his Pfizer sources that employees are being told to expect "deep cuts," with more details--and some actual pink slips--hitting in two weeks.

As you know, a Pfizer exec announced earlier this week that about $800 million in cost cuts were coming during the fourth quarter. Now, word that those cuts could include jobs are making analysts tout Pfizer shares. "I think the 7 percent yield is increasingly attractive in the current environment," uber-analyst Barbara Ryan of Deustche Bank told MarketWatch, referring to Pfizer's vaunted dividend. Ryan also said word of layoffs, plus Pfizer's strong cash position, are boosting the stock.

- read the story at MarketWatch
- check out the In the Pipeline post

Suggested Articles

Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story.

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.